Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ironwood Pharmaceuticals

0.8888
+0.01011.15%
Volume:1.62M
Turnover:1.41M
Market Cap:143.82M
PE:160.69
High:0.9337
Open:0.9300
Low:0.8200
Close:0.8787
Loading ...

Ironwood receives Nasdaq non-compliance notification

TIPRANKS
·
28 Mar

Ironwood Pharmaceuticals Announces Receipt of Nasdaq Non-Compliance Notification Regarding Late 2024 Form 10-K Filing

Business Wire
·
28 Mar

Catalyst (CPRX) Surges 6.2%: Is This an Indication of Further Gains?

Zacks
·
25 Mar

Is Ironwood Pharmaceuticals, Inc. (IRWD) the Best Small Cap Pharma Stocks to Buy Now?

Insider Monkey
·
03 Mar

IRWD's Q4 Earnings and Revenues Fall Shy of Estimates, Stock Down

Zacks
·
01 Mar

Ironwood Pharmaceuticals Inc (IRWD) Q4 2024 Earnings Call Highlights: Strong Prescription ...

GuruFocus.com
·
28 Feb

Q4 2024 Ironwood Pharmaceuticals Inc Earnings Call

Thomson Reuters StreetEvents
·
28 Feb

Ironwood Pharmaceuticals Reports 2024 Financial Results

TIPRANKS
·
28 Feb

Analysts Offer Insights on Healthcare Companies: Ironwood Pharma (IRWD) and Intellia Therapeutics (NTLA)

TIPRANKS
·
28 Feb

Ironwood Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
28 Feb

Ironwood Pharma (IRWD) Has a New Rating from Craig-Hallum

TIPRANKS
·
27 Feb

Ironwood Pharmaceuticals (IRWD) Q4 Earnings and Revenues Miss Estimates

Zacks
·
27 Feb

Ironwood: Q4 Earnings Snapshot

Associated Press Finance
·
27 Feb

Ironwood Pharmaceuticals 2025 Outlook: Expects Revenue Of $260M–$290M Vs. $287.583M Est., Sees Adjusted EBITDA Above $85M

Benzinga
·
27 Feb

Ironwood Pharmaceuticals Q4 2024 Adj EPS $0.02 Misses $0.08 Estimate, Sales $90.55M Miss $93.82M Estimate

Benzinga
·
27 Feb

BRIEF-Ironwood Pharmaceuticals Q4 Revenue USD 90.545 Million Vs. IBES Estimate USD 93.8 Million

Reuters
·
27 Feb

Ironwood Pharmaceuticals Inc - Outlook FY Total Revenue $260 - $290 Million

THOMSON REUTERS
·
27 Feb

Ironwood Pharmaceuticals Q4 Adjusted Ebitda USD 33.775 Million

THOMSON REUTERS
·
27 Feb

Ironwood Pharmaceuticals Q4 Basic EPS USD 0.02

THOMSON REUTERS
·
27 Feb

Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results; Achieves 2024 Financial Guidance

Business Wire
·
27 Feb